In the case of SARS, the switch to the human host was allowed by an adaption of the receptor binding domain of the spike (S) protein, conferring to binding capabilities to the human angiotensin-converting enzyme 2 (ACE2) (Huang et al., 2020; Perlman and Netland, 2009). This evidence concerns the gene ACE2 and severe acute respiratory syndrome.